Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663

Watchlist Manager
Bharat Immunologicals and Biologicals Corporation Ltd Logo
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Watchlist
Price: 23.21 INR -1.36% Market Closed
Market Cap: 1B INR
Have any thoughts about
Bharat Immunologicals and Biologicals Corporation Ltd?
Write Note

Bharat Immunologicals and Biologicals Corporation Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bharat Immunologicals and Biologicals Corporation Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Bharat Immunologicals and Biologicals Corporation Ltd
BSE:524663
Total Receivables
â‚ą100.3m
CAGR 3-Years
-15%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Transgene Biotek Ltd
BSE:526139
Total Receivables
â‚ą8.4B
CAGR 3-Years
4 542%
CAGR 5-Years
888%
CAGR 10-Years
N/A
Z
Zenotech Laboratories Ltd
BSE:532039
Total Receivables
â‚ą53m
CAGR 3-Years
23%
CAGR 5-Years
6%
CAGR 10-Years
20%
Hester Biosciences Ltd
NSE:HESTERBIO
Total Receivables
â‚ą999.1m
CAGR 3-Years
8%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Biocon Ltd
NSE:BIOCON
Total Receivables
â‚ą72.6B
CAGR 3-Years
83%
CAGR 5-Years
46%
CAGR 10-Years
25%
Panacea Biotec Ltd
NSE:PANACEABIO
Total Receivables
â‚ą670.8m
CAGR 3-Years
-19%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
No Stocks Found

Bharat Immunologicals and Biologicals Corporation Ltd
Glance View

Market Cap
1B INR
Industry
Biotechnology

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacture and market of pharmaceutical products. The company is headquartered in Bulandshahr, Uttar Pradesh. The firm is primarily engaged in the manufacture of Oral polio Vaccine, Zinc Tablets, Diarrhea management Kit and BIB Sweet Tablets. The company is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The firm is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). The company is also diversified into Plasma-derived medicines and Oral Cholera vaccines. The firm's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.

BIBCL Intrinsic Value
5.26 INR
Overvaluation 77%
Intrinsic Value
Price

See Also

What is Bharat Immunologicals and Biologicals Corporation Ltd's Total Receivables?
Total Receivables
100.3m INR

Based on the financial report for Sep 30, 2023, Bharat Immunologicals and Biologicals Corporation Ltd's Total Receivables amounts to 100.3m INR.

What is Bharat Immunologicals and Biologicals Corporation Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
2%

Over the last year, the Total Receivables growth was -64%. The average annual Total Receivables growth rates for Bharat Immunologicals and Biologicals Corporation Ltd have been -15% over the past three years , 2% over the past five years .

Back to Top